Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update
出版年份 2023 全文链接
标题
Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update
作者
关键词
-
出版物
THERAPEUTIC DRUG MONITORING
Volume -, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-09-20
DOI
10.1097/ftd.0000000000001113
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Insight into the current practice of ototoxicity monitoring during cisplatin therapy
- (2021) N. M. Santucci et al. Journal of Otolaryngology-Head & Neck Surgery
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity
- (2021) Peter S. Steyger American Journal of Audiology
- GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs
- (2020) Barna Budai et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- CYP Genotypes Are Associated with Toxicity and Survival in Osteosarcoma Patients
- (2020) Alini Trujillo-Paolillo et al. Journal of Adolescent and Young Adult Oncology
- Current Strategies to Combat Cisplatin-Induced Ototoxicity
- (2020) Dehong Yu et al. Frontiers in Pharmacology
- Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium
- (2019) Eva Clemens et al. LANCET ONCOLOGY
- A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy
- (2019) E. Clemens et al. PLoS One
- Pharmacogenomics of Cisplatin‐Induced Ototoxicity: Successes, Shortcomings and Future Avenues of Research
- (2019) Britt I. Drögemöller et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms
- (2019) Robyn Meech et al. PHYSIOLOGICAL REVIEWS
- Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)
- (2019) Chantal M. Driessen et al. Cancers
- GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation
- (2019) Eder C. Pincinato et al. Scientific Reports
- Cisplatin-Induced Ototoxicity: Updates on Molecular Targets
- (2019) Erica Gentilin et al. TRENDS IN MOLECULAR MEDICINE
- Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1
- (2019) Caner Turan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study
- (2019) Eva Clemens et al. PHARMACOGENOMICS JOURNAL
- Further Investigation of the Role ofACYP2andWFS1Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients
- (2018) Britt I. Drögemöller et al. CLINICAL CANCER RESEARCH
- Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients
- (2018) Guilherme Augusto Silva Nogueira et al. Oncotarget
- Association between genetic polymorphisms and platinum-induced ototoxicity in children
- (2018) Gabrielle Lui et al. Oncotarget
- Contribution of the GSTP1 c.313A>G variant to hearing loss risk in patients exposed to platin chemotherapy during childhood
- (2018) P. H. P. Liberman et al. Clinical & Translational Oncology
- Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients
- (2018) Wendy A. Teft et al. ORAL ONCOLOGY
- TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity
- (2017) Signe Thiesen et al. Pharmacogenetics and Genomics
- Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin
- (2017) Claudia Lanvers-Kaminsky et al. PHARMACOGENOMICS
- Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
- (2017) Sandeep Sheth et al. Frontiers in Cellular Neuroscience
- Cisplatin is retained in the cochlea indefinitely following chemotherapy
- (2017) Andrew M. Breglio et al. Nature Communications
- Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor
- (2017) Jeewon Kim et al. Oncotarget
- Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer
- (2017) Britt I. Drögemöller et al. JAMA Oncology
- Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
- (2016) Folefac Aminkeng et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Variants inWFS1and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
- (2016) Heather E. Wheeler et al. CLINICAL CANCER RESEARCH
- Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients
- (2016) Yüksel Olgun et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice
- (2016) R. N. Rainey et al. JOURNAL OF NEUROSCIENCE
- Early ototoxic changes in patients with germ cell tumor after first cycle of cisplatin-based therapy
- (2016) László Noszek et al. LARYNGOSCOPE
- Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma
- (2016) Hanneke I. Vos et al. Pharmacogenetics and Genomics
- Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin
- (2016) T F Spracklen et al. PHARMACOGENOMICS JOURNAL
- Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
- (2016) Jong W. Lee et al. THERAPEUTIC DRUG MONITORING
- XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation
- (2016) Leisa Lopes-Aguiar et al. Oncotarget
- Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool
- (2015) Zahra N. Sohani et al. BMC GENETICS
- Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma
- (2015) Guilherme Augusto Silva Nogueira et al. INTERNATIONAL JOURNAL OF CANCER
- Gene Expression by Mouse Inner Ear Hair Cells during Development
- (2015) D. I. Scheffer et al. JOURNAL OF NEUROSCIENCE
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
- (2015) Heng Xu et al. NATURE GENETICS
- Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity
- (2015) Claudia Lanvers-Kaminsky et al. PHARMACOGENOMICS
- Protective effect of Wuzhi tablet (Schisandra sphenanthera extract) against cisplatin-induced nephrotoxicity via Nrf2-mediated defense response
- (2015) Jing Jin et al. PHYTOMEDICINE
- Comprehensive Assessment of Genetic Sequence Variants in the Antioxidant ‘Master Regulator’ Nrf2 in Idiopathic Parkinson’s Disease
- (2015) Michael Todorovic et al. PLoS One
- SHIELD: an integrative gene expression database for inner ear research
- (2015) Jun Shen et al. Database-The Journal of Biological Databases and Curation
- SOD2genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma
- (2015) Austin L. Brown et al. Cancer Medicine
- Influence of Genetic Variants in TPMT and COMT Associated with Cisplatin Induced Hearing Loss in Patients with Cancer: Two New Cohorts and a Meta-Analysis Reveal Significant Heterogeneity between Cohorts
- (2015) Melanie M. Hagleitner et al. PLoS One
- Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity
- (2014) C Lanvers-Kaminsky et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
- (2014) Ursula Amstutz et al. EPILEPSIA
- Characterization of Transcriptomes of Cochlear Inner and Outer Hair Cells
- (2014) H. Liu et al. JOURNAL OF NEUROSCIENCE
- A ‘calcium capacitor’ shapes cholinergic inhibition of cochlear hair cells
- (2014) Paul Albert Fuchs JOURNAL OF PHYSIOLOGY-LONDON
- Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants
- (2014) Venkatesh Sampath et al. PEDIATRIC RESEARCH
- Genetic variation in Otos is associated with cisplatin-induced ototoxicity
- (2014) Timothy F Spracklen et al. PHARMACOGENOMICS
- The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer
- (2013) J J Yang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
- (2013) K Pussegoda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- SOD2 V16A SNP in the Mitochondrial Targeting Sequence is Associated with Noise Induced Hearing Loss in Chinese Workers
- (2013) Yi-Min Liu et al. DISEASE MARKERS
- Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer
- (2013) Tomoyo Oguri et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Functional Mechanotransduction Is Required for Cisplatin-Induced Hair Cell Death in the Zebrafish Lateral Line
- (2013) A. J. Thomas et al. JOURNAL OF NEUROSCIENCE
- Cisplatin-induced Ototoxicity in Pediatric Solid Tumors
- (2013) Worawut Choeyprasert et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels
- (2013) T. Suzuki et al. MOLECULAR AND CELLULAR BIOLOGY
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Pharmacogenomic association between a variant inSLC47A1gene and therapeutic response to metformin in type 2 diabetes
- (2012) I. Tkáč et al. DIABETES OBESITY & METABOLISM
- Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models
- (2012) Celia Casares et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale
- (2012) Penelope R. Brock et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel Animal Model of Hearing Loss Caused by Acute Endoplasmic Reticulum Stress in the Cochlea
- (2012) Yoshiaki Fujinami et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients
- (2012) Xiaojing Xu et al. LUNG CANCER
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma
- (2012) Surya Rednam et al. PEDIATRIC BLOOD & CANCER
- Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans
- (2012) Ewa D. Marczak et al. Pharmacogenetics and Genomics
- Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients
- (2011) Hong-Hee Won et al. CANCER
- Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart
- (2011) Maria Volkova et al. CARDIOVASCULAR RESEARCH
- Cisplatin ototoxicity in rat cochlear organotypic cultures
- (2011) Dalian Ding et al. HEARING RESEARCH
- Hair Cell Toxicity in Anti-cancer Drugs: Evaluating an Anti-cancer Drug Library for Independent and Synergistic Toxic Effects on Hair Cells Using the Zebrafish Lateral Line
- (2011) Yoshinobu Hirose et al. JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
- (2010) Giuliano Ciarimboli et al. AMERICAN JOURNAL OF PATHOLOGY
- Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity
- (2010) Takanori Nakamura et al. BIOCHEMICAL PHARMACOLOGY
- Practical Grading System for Evaluating Cisplatin Ototoxicity in Children
- (2010) Kay W. Chang et al. JOURNAL OF CLINICAL ONCOLOGY
- Roles of NADPH Oxidases in Cisplatin-Induced Reactive Oxygen Species Generation and Ototoxicity
- (2010) H.-J. Kim et al. JOURNAL OF NEUROSCIENCE
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
- (2009) K K Filipski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
- Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
- (2009) D Caronia et al. PHARMACOGENOMICS JOURNAL
- Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
- (2009) A V Khrunin et al. PHARMACOGENOMICS JOURNAL
- Evidence that Cisplatin-induced Auditory Damage is Attenuated by Downregulation of Pro-inflammatory Cytokines Via Nrf2/HO-1
- (2008) HongSeob So et al. JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY
- Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity
- (2008) V. Hellberg et al. JNCI-Journal of the National Cancer Institute
- Potentially functional polymorphisms of EXO1 and risk of lung cancer in a Chinese population: A case-control analysis
- (2008) Guangfu Jin et al. LUNG CANCER
- Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma
- (2008) Nadia Barahmani et al. NEURO-ONCOLOGY
- Modulation of DNA damage/DNA repair capacity by XPC polymorphisms
- (2007) Yimin Zhu et al. DNA REPAIR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search